(Q40074705)

reason for preferred rank

17 September 2017

title

Evidence for a defect in the formation of 1α,25-dihydroxyvitamin D in pseudohypoparathyroidism (English)

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

28 May 2022

Evidence for a defect in the formation of 1alpha,25-dihydroxyvitamin D in pseudohypoparathyroidism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194132

28 May 2022

main subject

pseudohypoparathyroidism

1 reference

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

28 May 2022

2

DeLuca HF

1 reference

17 September 2017

T. K. Sinha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194132

28 May 2022

H. F. DeLuca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194132

28 May 2022

N. H. Bell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194132

28 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=194132

28 May 2022

publication date

1 July 1977

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0026049577900609?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

https://api.elsevier.com/content/article/PII:0026049577900609?httpAccept=text/plain

28 May 2022

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

28 May 2022

1 reference

17 September 2017

volume

26

1 reference

17 September 2017

issue

7

1 reference

17 September 2017

page(s)

731-738

1 reference

Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism

28 May 2022

2

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Pseudohypoparathyroidism with Secondary Hyperparathyroidism and Osteitis Fibrosa*

28 May 2022

3

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

PSEUDOHYPOPARATHYROIDISM WITH OSTEITIS FIBROSA CYSTICA AND IMPAIRED ABSORPTION OF CALCIUM

28 May 2022

4

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

28 May 2022

HYPO-HYPERPARATHYROIDISM

5

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Renal resistance to parathyroid hormone with osteitis fibrosa: "pseudohypohyperparathyroidism".

28 May 2022

6

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol

28 May 2022

7

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Control of 25-hydroxycholecalciferol metabolism by parathyroid glands

28 May 2022

8

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone

28 May 2022

9

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

1,25-Dihydroxycholecalciferol Deficiency: The Probable Cause of Hypocalcemia and Metabolic Bone Disease in Pseudohypoparathyroidism

28 May 2022

10

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.

28 May 2022

11

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Determination of serum calcium by means of orthocresolphthalein complexone

28 May 2022

12

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Radioimmunoassay of human parathyroid hormone in serum

28 May 2022

15

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Demonstration of a Diurnal Variation in Serum Parathyroid Hormone in Primary and Secondary Hyperparathyroidism

28 May 2022

16

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

A rapid assay for 25-OH-vitamin D3 without preparative chromatography

28 May 2022

17

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Calcium and phosphorus metabolism parathyroid hormone, calcitonin and bone histology in pseudohypoparathyroidism

28 May 2022

19

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects.

28 May 2022

21

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Restoration of Parathyroid Responsiveness in Vitamin D—Deficient Rats by Parenteral Calcium or Dietary Lactose*

28 May 2022

23

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Response to Parathyroid Hormone Infusion in Primary Hyperparathyroidism

28 May 2022

24

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

On the lipolytic action of parathyroid hormone in man

28 May 2022

27

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

Parathyroid hormone stimulation of glucose and urea production in isolated liver cells

28 May 2022

28

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

The colorimetric determination of phosphorus

28 May 2022

13

1 reference

https://api.crossref.org/works/10.1016/0026-0495(77)90060-9

28 December 2022

Identifiers

1 reference

17 September 2017

1 reference